Naproxol

This classification denotes a nonsteroidal antiinflammatory drug, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 33S398GAY6. European Medicines Agency schedules Naproxol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09160MIG. Naproxol generally arises in the molecular formula C14H16O2. The term NAPROXOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 25 , no. 10 1971, list 11.) NAPROXOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule naproxol under HS 29094990 and SITC 51617. As of Q4 2014, NAPROXOL remains the US FDA Preferred Term for this commodity. Naproxol bears US NLM identifiers UMLS ID C2827277 and NCI Concept Code C83990. SMILES: OCC(C1CC2C(CC1)CC(OC)CC2)C.